1-1banner
 
medpundit
 

 
Commentary on medical news by a practicing physician.
 

 
Google
  • Epocrates MedSearch Drug Lookup




  • MASTER BLOGS





    "When many cures are offered for a disease, it means the disease is not curable" -Anton Chekhov




    ''Once you tell people there's a cure for something, the more likely they are to pressure doctors to prescribe it.''
    -Robert Ehrlich, drug advertising executive.




    "Opinions are like sphincters, everyone has one." - Chris Rangel



    email: medpundit-at-ameritech.net

    or if that doesn't work try:

    medpundit-at-en.com



    Medpundit RSS


    Quirky Museums and Fun Stuff


    Who is medpundit?


    Tech Central Station Columns



    Book Reviews:
    Read the Review

    Read the Review

    Read the Review

    More Reviews

    Second Hand Book Reviews

    Review


    Medical Blogs

    rangelMD

    DB's Medical Rants

    Family Medicine Notes

    Grunt Doc

    richard[WINTERS]

    code:theWebSocket

    Psychscape

    Code Blog: Tales of a Nurse

    Feet First

    Tales of Hoffman

    The Eyes Have It

    medmusings

    SOAP Notes

    Obels

    Cut-to -Cure

    Black Triangle

    CodeBlueBlog

    Medlogs

    Kevin, M.D

    The Lingual Nerve

    Galen's Log

    EchoJournal

    Shrinkette

    Doctor Mental

    Blogborygmi

    JournalClub

    Finestkind Clinic and Fish Market

    The Examining Room of Dr. Charles

    Chronicles of a Medical Mad House

    .PARALLEL UNIVERSES.

    SoundPractice

    Medgadget
    Health Facts and Fears

    Health Policy Blogs

    The Health Care Blog

    HealthLawProf Blog

    Facts & Fears

    Personal Favorites

    The Glittering Eye

    Day by Day

    BioEdge

    The Business Word Inc.

    Point of Law

    In the Pipeline

    Cronaca

    Tim Blair

    Jane Galt

    The Truth Laid Bear

    Jim Miller

    No Watermelons Allowed

    Winds of Change

    Science Blog

    A Chequer-Board of Night and Days

    Arts & Letters Daily

    Tech Central Station

    Blogcritics

    Overlawyered.com

    Quackwatch

    Junkscience

    The Skeptic's Dictionary



    Recommended Reading

    The Doctor Stories by William Carlos Williams


    Pox Americana: The Great Smallpox Epidemic of 1775-82 by Elizabeth Fenn


    Intoxicated by My Illness by Anatole Broyard


    Raising the Dead by Richard Selzer


    Autobiography of a Face by Lucy Grealy


    The Man Who Mistook His Wife for a Hat by Oliver Sacks


    The Sea and Poison by Shusaku Endo


    A Midwife's Tale by Laurel Thatcher Ulrich




    MEDICAL LINKS

    familydoctor.org

    American Academy of Pediatrics

    General Health Info

    Travel Advice from the CDC

    NIH Medical Library Info

     



    button

    Friday, December 27, 2002

    That Gnawing Feeling: The media isn’t quite sure what to make of the recent study comparing Celebrex to Voltaren + Prilosec for arthritits treatment. Reuters says "Celebrex fails to alter risk of new ulcers", while an Associated Press headline claims, "Study links new arthritis drugs to ulcers."

    Celebrex is one of the newer arthritis medications that is supposed to have a lower incidence of stomach upset and ulcers than the older arthritis drugs like ibuprofen or aspirin. The study compared the incidence of ulcers in people who used Celebrex alone compared to people who used diclofenac (brand name Cataflam or Voltaren), an older arthritits drug, paired with an ulcer prevention drug, omeprazole (brand name Prilosec).

    The dose of Celebrex in the study was 200 mg twice a day. That costs $148 a month. The dose of diclofenac was 75 mg twice a day, which costs $27 a month for the generic version. Add omeprazole, and you add another $99 a month to the price tag, for a total of $126 a month. So, just what did they find? That the two treatments were comparable:

    In the intention-to-treat analysis, which included 287 patients (144 receiving celecoxib and 143 receiving diclofenac plus omeprazole), recurrent ulcer bleeding occurred in 7 patients receiving celecoxib and 9 receiving diclofenac plus omeprazole. The probability of recurrent bleeding during the six-month period was 4.9 percent (95 percent confidence interval, 3.1 to 6.7) for patients who received celecoxib and 6.4 percent (95 percent confidence interval, 4.3 to 8.4) for patients who received diclofenac plus omeprazole (difference, –1.5 percentage points; 95 percent confidence interval for the difference, –6.8 to 3.8). Renal adverse events, including hypertension, peripheral edema, and renal failure, occurred in 24.3 percent of the patients receiving celecoxib and 30.8 percent of those receiving diclofenac plus omeprazole.

    So, Celebrex may not be any better than the cheaper and older therapy when it comes to ulcer risk, but only if that cheaper and older therapy is taken with an anti-ulcer pill. Unfortunately, the addition of that anti-ulcer pill makes the regimen only marginally less expensive than Celebrex alone. There's another concern about using two drugs when one will do. The more drugs ingested, the greater the risk of side effects and drug-to-drug interactions. Omeprazole interacts with a long list of other drugs. So do Voltaren and Celebrex. In the end, it’s always best to try to simplify a medical regimen as much as possible and avoid using two drugs when one would do just as well. If the $20 a month difference is going to strain the pocket book, then by all means the cheaper combo would be fine, but otherwise, the one drug regimen of Celebrex would be the better choice.
     

    posted by Sydney on 12/27/2002 08:13:00 AM 0 comments

    0 Comments:

    Post a Comment

    This page is powered by Blogger, the easy way to update your web site.

    Main Page

    Ads

    Home   |   Archives

    Copyright 2006